Among several candidates, ASPA was selected for further investigation as it was the differentially expressed gene (DEG) most significantly associated with progression-free survival (PFS) in PCa, as validated by four Gene Expression Omnibus (GEO) datasets. The gene discussed is ASPA; the disease is posterior cortical atrophy.